As of 2025-02-17, the Relative Valuation of Cara Therapeutics Inc (CARA) is (357.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.20 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -6973.7%.
The range of the Relative Valuation is (311.03) - (407.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 14.9x - 19.5x | 17.3x |
Forward P/E multiples | 14.3x - 20.2x | 16.9x |
Fair Price | (311.03) - (407.18) | (357.43) |
Upside | -6081.4% - -7930.4% | -6973.7% |
Date | P/E |
2025-02-07 | -0.24 |
2025-02-06 | -0.24 |
2025-02-05 | -0.24 |
2025-02-04 | -0.23 |
2025-02-03 | -0.23 |
2025-01-31 | -0.23 |
2025-01-30 | -0.24 |
2025-01-29 | -0.24 |
2025-01-28 | -0.23 |
2025-01-27 | -0.26 |
2025-01-24 | -0.29 |
2025-01-23 | -0.24 |
2025-01-22 | -0.23 |
2025-01-21 | -0.22 |
2025-01-17 | -0.22 |
2025-01-16 | -0.22 |
2025-01-15 | -0.21 |
2025-01-14 | -0.22 |
2025-01-13 | -0.22 |
2025-01-10 | -0.23 |
2025-01-08 | -0.23 |
2025-01-07 | -0.23 |
2025-01-06 | -0.25 |
2025-01-03 | -0.25 |
2025-01-02 | -0.26 |
2024-12-31 | -0.29 |
2024-12-30 | -0.20 |
2024-12-27 | -0.22 |
2024-12-26 | -0.26 |
2024-12-24 | -0.27 |
2024-12-23 | -0.26 |
2024-12-20 | -0.24 |
2024-12-19 | -0.23 |
2024-12-18 | -0.15 |
2024-12-17 | -0.14 |
2024-12-16 | -0.15 |
2024-12-13 | -0.15 |
2024-12-12 | -0.15 |
2024-12-11 | -0.15 |
2024-12-10 | -0.16 |
2024-12-09 | -0.17 |
2024-12-06 | -0.15 |
2024-12-05 | -0.15 |
2024-12-04 | -0.16 |
2024-12-03 | -0.16 |
2024-12-02 | -0.17 |
2024-11-29 | -0.17 |
2024-11-27 | -0.17 |
2024-11-26 | -0.17 |
2024-11-25 | -0.17 |